The latest version of cNeuro® includes the launch of the Dementia Differential Analysis report, new disease-specific reports, additional automated MRI quantifications and imaging biomarkers, and more.
Attending AAIC 2022? Stop by booth 400 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Attending ECR 2022? Stop by booth AI-09 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
ASNR22 provided a great opportunity to discuss tools that would help neuroradiologists support their referring clinicians when diagnosing patients with symptoms of dementia. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, and Greg Kingston, Combinostics Chief Marketing Officer (CMO).
Our industry-first Dementia Differential Analysis report is based on MRI data only and compares the patient’s data against reference data from thousands of previous patients.
Attending the 103rd German X-Ray Congress? Stop by booth Nord 39 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
AAN 2022 highlighted cutting-edge research in neurology and provided opportunities for networking within the neurology community. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, from advances for traumatic brain injury to the future of AI and neurology.
Tom Gardner has joined Combinostics as the Vice President of US Sales. He has over 25 years of experience successfully developing and leading sales teams in the AI and clinical imaging software solutions space.
Attending ASNR22? Stop by Booth #109 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
ACTRIMS 2022 highlighted novel scientific discoveries for multiple sclerosis (MS), with a focus on MS biomarkers. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, from better, novel treatments to the potential of enhanced AI-based neuroimaging for improved patient management.
© Combinostics | Privacy Policy